Restricted Research - Award List, Note/Discussion Page
Fiscal Year: 2023
1155 University of Houston (143043)
Principal Investigator: Naash,Muna
Total Amount of Contract, Award, or Gift (Annual before 2011): $ 1,603,148
Exceeds $250,000 (Is it flagged?): Yes
Start and End Dates: 1/1/23 - 12/31/26
Restricted Research: YES
Academic Discipline: Biomedical Engineering
Department, Center, School, or Institute: Biomedical Engineering
Title of Contract, Award, or Gift: NON-VIRAL GENE DELIVERY PLATFORMS FOR THE TREATMENT OF USHER SYNDROME TYPE 2A
Name of Granting or Contracting Agency/Entity:
National Eye Institute
CFDA Link: HHS
93.867
Program Title:
n/a
CFDA Linked: Vision Research
Note:
Our goal is to advance our current intravitreal gene therapy platform consisting of DNA nanoparticles (DNA-NPs)/hyaluronic acid nanospheres (HA-NSs) to deliver large genes in order to develop safe/effective therapies for visual loss in Usher Syndrome type 2A (USH2A). SAMs 1.1.1
Discussion: No discussion notes